36 MONTHS SURVIVABILITY AND ITS PREDICTORS IN PATIENTS WITH CHRONIC HEART FAILURE AND DECREASED FRACTION OF LEFT VENTRICULAR EJECTION DEPENDING ON SEX

Author:

Voronkov Leonid1,Filatova Elena1,Lyashenko Alina1,Tkach Natalya1,Babych Pavel2

Affiliation:

1. National Scientific Center “M. D. Strazhesko of NAMS of Ukraine”

2. State Expert Center of Ministry of Health of Ukraine

Abstract

Aim of the work: to compare survivability parameters during 36 months and their predictors among men and women with chronic heart failure and decreased fraction of left ventricular ejection. Materials and methods: the research included 356 patients with CHF (NYHA ІІ –ІV) with decreased LVEF<40 %, 18–75 years old. Using Kaplan-Meier method, there was analyzed the survivability in men and women during 36 months, then there were analyzed independent factors that influenced survivability terms depending on sex using the multiple logistic regression. Results. Our analysis of the survivability of patients with CHF with decreased LVEF demonstrated that the cumulative survival after 3 years of observation was 49 and 51 % for men and women, respectively. The curves of 36 months survivability didn’t reliably differ. At the analysis of factors, associated with the bad prognosis, there were observed differences between groups of men and women with CHF. Thus, in men the predictors of 36 month survival were: the thickness of the right ventricle wall, size of the right atrium, end-diastolic volume and end-systolic volume of LV, indices of EDV and ESV of LV, urinary acid level, value of LVEF. In women the predictors of survivability during 3 years were the following parameters: BMI, DM type 2 in an anamnesis, end-diastolic size of LV, end-systolic size of LV, blood glucose level, LVEF. Conclusion. The survivability of men and women with CHF with decreased LVEF during 36 months didn’t reliably differ and was 49 and 51 % respectively. But predictors of the lethal outcome in men and women essentially differed during 36 months, and their number is essentially higher in men.

Publisher

OU Scientific Route

Reference20 articles.

1. Voronkov, L. G. (2012). A patient with CHF in Ukraine: an analysis of the data of the population of patients surveyed in the framework of the first national study UNIVERS. Sertseva nedostatnist [Heart Failure], 2, 6–13.

2. Drozdova, I. V., Vasylieva, L. O., Babets, A. A. (2016). Tserebro-vaskuliarni khvoroby v Ukraini: do pytannia analizu ta prohnozuvannia. East European Scientific Journal, 6 (10), 8–12.

3. Kovalenko, V. M., Dorogoy, A. P. (2016). Sertsevo-sudinn hvorobi: medichno-sotsialne znachennya ta strategiya rozvitku kardiologiyi v Ukrayini. Ukrayinskiy kardiologichniy zhurnal [Ukrainian Cardiology Journal], 3, 5–14.

4. Mozaffarian, D., Benjamin, E. J., Go, A. S., Arnett, D. K., Blaha, M. J., Cushman, M. et. al. (2015). Heart Disease and Stroke Statistics–2015 Update. Circulation, 131 (4), 29–322. doi:10.1161/cir.0000000000000152

5. Gastelurrutia, P., Gastelurrutia, M. A., Faus, M. J., Bayes-Genis, A. (2012). Common health problems management uncertainties in heart failure: a qualitative study. Farmacia hospitalaria, 36 (6), 498–505.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3